BOSTON, Sept. 1, 2015 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced that its Chief Executive Officer, Alan Milinazzo, will present at the Rodman & Renshaw 17th Annual Global Conference on Thursday, September 10, 2015 at 10:25 a.m. ET. The conference will be held in New York, NY.
A live webcast will be available for those participants who are unable to attend, which can be found at: http://wsw.com/webcast/rrshq25/nspr. The webcast will be available for 180 days following the presentation.
About InspireMD, Inc.
InspireMD (www.inspiremd.com) seeks to utilize its proprietary MGuard™ with MicroNetTM technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuardTM), neurovascular, and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.
Investor Contacts:
InspireMD, Inc.
Craig Shore
Chief Financial Officer
Phone: 1-888-776-6804
Email: craigs@inspiremd.com
PCG Advisory
Vivian Cervantes
Investor Relations
Phone: (212) 554-5482
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/inspiremd-to-present-at-the-rodman--renshaw-17th-annual-global-investment-conference-300135631.html
SOURCE InspireMD, Inc.
